Carbon monoxide inhibits Fas activating antibody-induced apoptosis in endothelial cells

Medical Gas Research

Volumn 1, Issue 1, 2011, Pages

  Wang, Xue ^a   Wang, Yong ^a   Lee, Seon Jin ^b   Kim, Hong Pyo ^c   Choi, Augustine M K ^b   Ryter, Stefan W ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c University of Ulsan   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CASPASE 3; CASPASE 8; CASPASE 9; DEATH DOMAIN RECEPTOR SIGNALING ADAPTOR PROTEIN; FAS ACTIVATING ANTIBODY; FAS ASSOCIATED DEATH DOMAIN PROTEIN; FAS LIGAND; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN ANTIBODY; PROTEIN BAX; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; IMMUNOPRECIPITATION; IN VITRO STUDY; INTRACELLULAR SIGNALING; LUNG ENDOTHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; WESTERN BLOTTING;

EID: 84866017844     PISSN: None     EISSN: 20459912     Source Type: Journal    
DOI: 10.1186/2045-9912-1-8     Document Type: Article

References (57)

1. To die or not to die: an overview of apoptosis and its role in disease. Hetts SW, JAMA 1998 279 300 307 10.1001/jama.279.4.300 9450715 (Pubitemid 28071022)
2. Apoptosis signaling. Strasser A, O'Connor L, Dixit VM, Annu Rev Biochem 2000 69 217 245 10.1146/annurev.biochem.69.1.217 10966458
3. Soluble Fas ligand induces epithelial cell apoptosis in humans with acute lung injury (ARDS). Matute-Bello G, Liles WC, Steinberg KP, Kiener PA, Mongovin S, Chi EY, Jonas M, Martin TR, J Immunol 1999 163 2217 2225 10438964 (Pubitemid 29382230)
4. Injurious mechanical ventilation and end-organ epithelial cell apoptosis and organ dysfunction in an experimental model of acute respiratory distress syndrome. Imai Y, Parodo J, Kajikawa O, de Perrot M, Fischer S, Edwards V, Cutz E, Liu M, Keshavjee S, Martin TR, Marshall JC, Ranieri VM, Slutsky AS, JAMA 2003 289 2104 2112 10.1001/jama.289.16.2104 12709468 (Pubitemid 37430212)
5. State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Tuder RM, Yoshida T, Arap W, Pasqualini R, Petrache I, Proc Am Thorac Soc 2006 3 503 510 10.1513/pats.200603-054MS 16921129 (Pubitemid 44285536)
6. Breaking the mitochondrial barrier. Martinou JC, Green DR, Nat Rev Mol Cell Biol 2001 2 63 67 10.1038/35048069 11413467 (Pubitemid 33676963)
7. Bax oligomerization is required for channel-forming activity in liposomes and to trigger cytochrome c release from mitochondria. Antonsson B, Montessuit S, Lauper S, Eskes R, Martinou JC, Biochem J 2000 345 271 278 10.1042/0264-6021:3450271 10620504 (Pubitemid 30077167)
8. BH3-Only proteins-essential initiators of apoptotic cell death. Huang DC, Strasser A, Cell 2000 103 839 842 10.1016/S0092-8674(00)00187-2 11136969
9. The CD95(APO-1/Fas) DISC and beyond. Peter ME, Krammer PH, Cell Death Differ 2003 10 26 35 10.1038/sj.cdd.4401186 12655293 (Pubitemid 36511830)
10. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME, EMBO J 1995 14 5579 5588 8521815
11. The "fuzzy logic" of the death-inducing signaling complex in lymphocytes. Walsh CM, Luhrs KA, Arechiga AF, J Clin Immunol 2003 23 333 353 10.1023/A:1025313415487 14601642 (Pubitemid 37083188)
12. c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis. Mathas S, Lietz A, Anagnostopoulos I, Hummel F, Wiesner B, Janz M, Jundt F, Hirsch B, Johrens-Leder K, Vornlocher HP, Bommert K, Stein H, Dorken B, J Exp Med 2004 199 1041 1052 10.1084/jem.20031080 15078899 (Pubitemid 38619901)
13. FLIP protein and TRAIL-induced apoptosis. Roth W, Reed JC, Vitam Horm 2004 67 189 206 15110178 (Pubitemid 39753664)
14. Cellular FLICE-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. Krueger A, Schmitz I, Baumann S, Krammer PH, Kirchhoff S, J Biol Chem 2001 276 20633 20640 10.1074/jbc.M101780200 11279218
15. c-FLIPR, a new regulator of death receptor-induced apoptosis. Golks A, Brenner D, Fritsch C, Krammer PH, Lavrik IN, J Biol Chem 2005 280 14507 14513 10.1074/jbc.M414425200 15701649 (Pubitemid 40562792)
16. PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability. Kaunisto A, Kochin V, Asaoka T, Mikhailov A, Poukkula M, Meinander A, Eriksson JE, Cell Death Differ 2009 16 1215 1126 10.1038/cdd.2009.35 19343040
17. Necrotic cell death in response to oxidant stress involves the activation of the apoptogenic caspase-8/bid pathway. Wang X, Ryter SW, Dai C, Tang Z, Watkins SC, Yin X, Song R, Choi AM, J Biol Chem 2003 278 29184 29191 10.1074/jbc.M301624200 12754217 (Pubitemid 36935834)
18. FLIP inhibits endothelial cell apoptosis during hyperoxia by suppressing Bax. Wang X, Wang Y, Kim HP, Choi AM, Ryter SW, Free Radic Biol Med 2007 42 1599 1609 10.1016/j.freeradbiomed.2007.02.020 17448907 (Pubitemid 46613941)
19. FLIP protects against hypoxia/reoxygenation-induced endothelial cell apoptosis by inhibiting Bax activation. Wang X, Wang Y, Zhang J, Kim HP, Ryter SW, Choi AM, Mol Cell Biol >2005 25 4742 4751 10.1128/MCB.25.11.4742-4751. 2005 15899875 (Pubitemid 40705776)
20. Microsomal heme oxygenase. Characterization of the enzyme. Tenhunen R, Marver H, Schmid R, J Biol Chem 1969 244 6388 6394 4390967
21. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Ryter SW, Alam J, Choi AM, Physiol Rev 2006 86 583 650 10.1152/physrev.00011.2005 16601269
22. Carbon monoxide controls the proliferation of hypoxic vascular smooth muscle cells. Morita T, Mitsialis SA, Koike H, Liu Y, Kourembanas S, J Biol Chem 1997 272 32804 32809 10.1074/jbc.272.52.32804 9407056 (Pubitemid 28023614)
23. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Otterbein LE, Bach FH, Alam J, Soares M, Tao Lu H, Wysk M, Davis RJ, Flavell RA, Choi AM, Nat Med 2000 6 422 428 10.1038/74680 10742149 (Pubitemid 30208159)
24. Carbon monoxide induces cytoprotection in rat orthotopic lung transplantation via anti-inflammatory and anti-apoptotic effects. Song R, Kubo M, Morse D, Zhou Z, Zhang X, Dauber JH, Fabisiak J, Alber SM, Watkins SC, Zuckerbraun BS, Otterbein LE, Ning W, Oury TD, Lee PJ, McCurry K. R, Choi AM, Am J Pathol 2003 163 231 242 10.1016/S0002-9440(10)63646-2 12819027 (Pubitemid 36759607)
25. Carbon monoxide generated by heme oxygenase 1 suppresses endothelial cell apoptosis. Brouard S, Otterbein LE, Anrathe J, Tobiasch E, Bach FH, Choi AM, Soares MP, J Exp Med 2000 192 1015 1026 10.1084/jem.192.7.1015 11015442
26. Carbon monoxide inhibits apoptosis in vascular smooth muscle cells. Liu XM, Chapman GB, Peyton KJ, Schafer AI, Durante W, Cardiovasc Res 2002 55 396 405 10.1016/S0008-6363(02)00410-8 12123779 (Pubitemid 34775290)
27. Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury. Zhang X, Shan P, Alam J, Fu XY, Lee PJ, J Biol Chem 2004 280 8714 8721 10.1074/jbc.M408092200 15590660 (Pubitemid 40409558)
28. MKK3 mitogen-activated protein kinase pathway mediates carbon monoxide-induced protection against oxidant-induced lung injury. Otterbein LE, Otterbein SL, Ifedigbo E, Liu F, Morse DE, Fearns C, Ulevitch RJ, Knickelbein R, Flavell RA, Choi AM, Am J Pathol 2003 163 2555 2563 10.1016/S0002-9440(10) 63610-3 14633627 (Pubitemid 37466496)
29. Carbon monoxide provides protection against hyperoxic lung injury. Otterbein LE, Mantell LL, Choi AM, Am J Physiol 1999 276 688 L694 10198367
30. Carbon monoxide modulates Fas/Fas ligand, caspases, and Bcl-2 family proteins via the p38alpha mitogen-activated protein kinase pathway during ischemia-reperfusion lung injury. Zhang X, Shan P, Alam J, Davis RJ, Flavell RA, Lee PJ, J Biol Chem 2003 278 22061 22070 10.1074/jbc.M301858200 12690100 (Pubitemid 36792616)
31. Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury. Otterbein LE, Zuckerbraun BS, Haga M, Liu F, Song R, Usheva A, Stachulak C, Smith RN, Csizmadia E, Tyagi S, Akamatsu Y, Flavell RJ, Billiar TR, Tzeng E, Soares MP, Nat Med 2003 9 183 190 10.1038/nm817 12539038 (Pubitemid 36227720)
32. Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. Lavitrano M, Smolenski RT, Musumeci A, Maccherini M, Slominska E, Di Florio E, Bracco A, Mancini A, Stassi G, Patti M, Giovannoni R, Froio A, Simeone F, Forni M, Bacci ML, D'Alise G, Cozzi E, Otterbein LE, Yacoub MH, Bach FH, Calise F, FASEB J 2004 18 1093 1095 15132974 (Pubitemid 39561534)
33. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Neto JS, Nakao A, Kimizuka K, Romanosky AJ, Stolz DB, Uchiyama T, Nalesnik MA, Otterbein LE, Murase N, Am J Physiol Renal Physiol 2004 287 979 F989 10.1152/ajprenal.00158.2004 15292046 (Pubitemid 39391095)
34. Carbon monoxide in biology and medicine. Ryter S, Otterbein L, Bioessays 2004 26 270 280 10.1002/bies.20005 14988928 (Pubitemid 38325668)
35. CO as a cellular signaling molecule. Kim HP, Ryter SW, Choi AM, Ann Rev Pharm Tox 2006 46 411 449 10.1146/annurev.pharmtox.46.120604.141053 (Pubitemid 43271196)
36. Heme oxygenase-1 inhibits TNF-alpha-induced apoptosis in cultured fibroblasts. Petrache I, Otterbein LE, Alam J, Wiegand GW, Choi AM, Am J Physiol Lung Cell Mol Physiol 2000 278 312 L319 10666115
37. Carbon monoxide protects against hyperoxia-induced endothelial cell apoptosis by inhibiting reactive oxygen species formation. Wang X, Wang Y, Kim HP, Ryter SW, Choi AM, J Biol Chem 2007 282 1718 726 17135272 (Pubitemid 47076716)
38. Bcl-XL disrupts death-inducing signal complex formation in plasma membrane induced by hypoxia/reoxygenation. Wang X, Zhang J, Kim HP, Wang Y, Choi AM, Ryter SW, FASEB J 2004 18 1826 1833 10.1096/fj.04-2047com 15576486 (Pubitemid 39602269)
39. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis. Brouard S, Berberat PO, Tobiasch E, Seldon MP, Bach FH, Soares MP, J Biol Chem 2002 277 17950 17961 10.1074/jbc.M108317200 11880364 (Pubitemid 34967606)
40. Carbon monoxide promotes Fas/CD95-induced apoptosis in Jurkat cells. Song R, Zhou Z, Kim PK, Shapiro RA, Liu F, Ferran C, Choi AM, Otterbein LE, J Biol Chem 2004 279 44327 44334 10.1074/jbc.M406105200 15280387 (Pubitemid 39430837)
41. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Li Y, Takemura G, Kosai K, Takahashi T, Okada H, Miyata S, Yuge K, Nagano S, Esaki M, Khai NC, Goto K, Mikami A, Maruyama R, Minatoguchi S, Fujiwara T, Fujiwara H, Circ Res 2004 95 627 636 10.1161/01.RES.0000141528.54850.bd 15297380 (Pubitemid 39274378)
42. Upregulation of two death pathways of perforin/granzyme and FasL/Fas in septic acute respiratory distress syndrome. Hashimoto S, Kobayashi A, Kooguchi K, Kitamura Y, Onodera H, Nakajima H, Am J Respir Crit Care Med 2000 161 237 243 10619826 (Pubitemid 30055931)
43. Fas/FasL-dependent apoptosis of alveolar cells after lipopolysaccharide- induced lung injury in mice. Kitamura Y, Hashimoto S, Mizuta N, Kobayashi A, Kooguchi K, Fujiwara I, Nakajima H, Am J Respir Crit Care Med 2001 163 762 769 11254536 (Pubitemid 32230841)
44. Phosphorylation of FADD/MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase. Scaffidi C, Volkland J, Blomberg I, Hoffmann I, Krammer PH, Peter ME, J Immunol 2000 164 1236 1242 10640736 (Pubitemid 30067235)
45. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Hua ZC, Sohn SJ, Kang C, Cado D, Winoto A, Immunity 2003 18 513 521 10.1016/S1074- 7613(03)00083-9 12705854 (Pubitemid 36513633)
46. Mitotic death: a mechanism of survival? A review. Erenpreisa J, Cragg MS, Cancer Cell Int 2001 1 1 10.1186/1475-2867-1-1 11983025 (Pubitemid 38751048)
47. FADD and its phosphorylation. Zhang J, Zhang D, Hua Z, IUBMB Life 2004 56 395 401 10.1080/15216540400008929 15545216 (Pubitemid 39564303)
48. Phosphorylation of FADD is critical for sensitivity to anticancer drug-induced apoptosis. Shimada K, Matsuyoshi S, Nakamura M, Ishida E, Kishi M, Konishi N, Carcinogenesis 2004 25 1089 1097 10.1093/carcin/bgh130 15001534 (Pubitemid 38968037)
49. Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities. Alappat EC, Feig C, Boyerinas B, Volkland J, Samuels M, Murmann AE, Thorburn A, Kidd VJ, Slaughter CA, Osborn SL, Winoto A, Tang WJ, Peter ME, Mol Cell 2005 19 321 332 10.1016/j.molcel.2005.06.024 16061179 (Pubitemid 41074888)
50. FADD phosphorylation is critical for cell cycle regulation in breast cancer cells. Matsuyoshi S, Shimada K, Nakamura M, Ishida E, Konishi N, Br J Cancer 2006 94 532 539 10.1038/sj.bjc.6602955 16450001 (Pubitemid 43289757)
51. Activation of JNK by vanadate induces a Fas-associated death domain (FADD)-dependent death of cerebellar granule progenitors in vitro. Luo J, Sun Y, Lin H, Qian Y, Li Z, Leonard SS, Huang C, Shi X, J Biol Chem 2003 278 4542 4551 10.1074/jbc.M208295200 12454017 (Pubitemid 36800951)
52. MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly. Holmström TH, Schmitz I, Söderström TS, Poukkula M, Johnson VL, Chow SC, Krammer PH, Eriksson JE, EMBO J 2000 19 5418 5428 10.1093/emboj/19.20.5418 11032809
53. Up-regulation of FLIP in cisplatin-selected HeLa cells causes cross-resistance to CD95/Fas death signaling. Kamarajan P, Sun NK, Chao CC, Biochem J 2003 376 253 260 10.1042/BJ20030659 12911332 (Pubitemid 37487221)
54. Notch3 signaling in vascular smooth muscle cells induces c-FLIP expression via ERK/MAPK activation. Resistance to Fas ligand-induced apoptosis. Wang W, Prince CZ, Mou Y, Pollman MJ, J Biol Chem 2002 277 21723 21729 10.1074/jbc.M202224200 11925448 (Pubitemid 34952323)
55. FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide. Bannerman DD, Eiting KT, Winn RK, Harlan JM, Am J Pathol 2004 165 1423 1431 10.1016/S0002-9440(10)63400-1 15466406 (Pubitemid 39297746)
56. Nuclear factor kappaB-mediated induction of Flice-like inhibitory protein prevents tumor necrosis factor alpha-induced apoptosis in rat granulosa cells. Xiao CW, Asselin E, Tsang BK, Biol Reprod 2002 67 436 441 10.1095/biolreprod67. 2.436 12135878 (Pubitemid 34803926)
57. Deficiency of survivin in transgenic mice exacerbates Fas-induced apoptosis via mitochondrial pathways. Conway EM, Pollefeyt S, Steiner-Mosonyi M, Luo W, Devriese A, Lupu F, Bono F, Leducq N, Dol F, Schaeffer P, Collen D, Herbert JM, Gastroenterology 2002 123 619 631 10.1053/gast.2002.34753 12145814 (Pubitemid 34827205)